Crohnʹs disease (CD) is a chronic inflammatory bowel disease with a progressive course, potentially affecting the entire gastrointestinal tract from mouth to anus. Several studies have shown an increased risk of both intestinal and extra‐intestinal cancer in patients with CD, due to long‐standing transmural inflammation and damage accumulation. The similarity of symptoms among CD, its related complications and the de novo onset of gastrointestinal cancer raises difficulties in the differential diagnosis. In addition, once a cancer diagnosis in CD patients is made, selecting the appropriate treatment can be particularly challenging. Indeed, both surgical and oncological treatments are not always the same as that of the general population, due to the inflammatory context of the gastrointestinal tract and the potential exacerbation of gastrointestinal symptoms of patients with CD; moreover, the overlap of the neoplastic disease could lead to adjustments in the pharmacological treatment of the underlying CD, especially with regard to immunosuppressive drugs. For these reasons, a case‐by‐case analysis in a multidisciplinary approach is often appropriate for the best diagnostic and therapeutic evaluation of patients with CD after gastrointestinal cancer onset.

Fiorillo, C., Schena, C. A., Quero, G., Laterza, V., Pugliese, D., Privitera, G., Rosa, F., Schepis, T., Salvatore, L., Di Stefano, B., Larosa, L., Minordi, L. M., Natale, L., Tortora, G., Armuzzi, A., Alfieri, S., Challenges in crohn’s disease management after gastrointestinal cancer diagnosis, <<CANCERS>>, 2021; 13 (3): 1-26. [doi:10.3390/cancers13030574] [http://hdl.handle.net/10807/174909]

Challenges in crohn’s disease management after gastrointestinal cancer diagnosis

Fiorillo;C.; Schena;C. A.; Quero;G.; Laterza;G.; Rosa;F.; Schepis;T.; Salvatore;B.; Larosa;L.; Minordi;L. M.; Natale;L.; Tortora;G.; Armuzzi;A.; Alfieri
2021

Abstract

Crohnʹs disease (CD) is a chronic inflammatory bowel disease with a progressive course, potentially affecting the entire gastrointestinal tract from mouth to anus. Several studies have shown an increased risk of both intestinal and extra‐intestinal cancer in patients with CD, due to long‐standing transmural inflammation and damage accumulation. The similarity of symptoms among CD, its related complications and the de novo onset of gastrointestinal cancer raises difficulties in the differential diagnosis. In addition, once a cancer diagnosis in CD patients is made, selecting the appropriate treatment can be particularly challenging. Indeed, both surgical and oncological treatments are not always the same as that of the general population, due to the inflammatory context of the gastrointestinal tract and the potential exacerbation of gastrointestinal symptoms of patients with CD; moreover, the overlap of the neoplastic disease could lead to adjustments in the pharmacological treatment of the underlying CD, especially with regard to immunosuppressive drugs. For these reasons, a case‐by‐case analysis in a multidisciplinary approach is often appropriate for the best diagnostic and therapeutic evaluation of patients with CD after gastrointestinal cancer onset.
Inglese
Fiorillo, C., Schena, C. A., Quero, G., Laterza, V., Pugliese, D., Privitera, G., Rosa, F., Schepis, T., Salvatore, L., Di Stefano, B., Larosa, L., Minordi, L. M., Natale, L., Tortora, G., Armuzzi, A., Alfieri, S., Challenges in crohn’s disease management after gastrointestinal cancer diagnosis, <<CANCERS>>, 2021; 13 (3): 1-26. [doi:10.3390/cancers13030574] [http://hdl.handle.net/10807/174909]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/174909
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact